Open AccessSeroprevalence of SARS‐CoV‐2 antibodies among pregnant women in Estonia: A call for epidemiological studies
Author(s) -
Veerus Piret,
Salumets Andres,
Naaber Paul,
Krjutškov Kaarel,
Tilk Kadi,
Laanpere Made,
Uusküla Anneli
Publication year - 2020
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1111/aogs.13995
Subject(s) - medicine , seroprevalence , epidemiology , pregnancy , population , obstetrics , pandemic , antibody , disease , immunology , serology , pediatrics , covid-19 , infectious disease (medical specialty) , environmental health , biology , genetics
Abstract On April 7, 2020 Mehreen Zaigham and Ola Andersson published a systematic review of maternal and perinatal outcomes in 108 pregnancies with Covid‐19 concluding that careful monitoring of such pregnancies and is warranted.1 We would like to emphasise the need to assess objectively the impact of the novel Severe Acute Respiratory Coronavirus Type 2 (SARS‐CoV‐2) causing Covid‐19 disease on pregnancy and perinatal outcomes by conducting epidemiological studies among pregnant women.